Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenestin 0.3 mg for Vasomotor Symptoms in Postmenopausal Women
NCT00272935Phase 3Completed
- Sponsor
- Duramed Research
- Start
- Dec 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of conjugated estrogens in vasomotor symptoms, sponsored by Duramed Research. Started Dec 2005; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00272935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272935.